Skip to main content
Clinical Trials/NCT02040701
NCT02040701UnknownNot Applicable

Sleep Disordered Breathing in Children: Inflammation and Oxidative Stress

Tel-Aviv Sourasky Medical Center1 site in 1 country300 target enrollmentStarted: May 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
300
Locations
1
Primary Endpoint
Plasma inflammatory-markers

Study Overview

Brief Summary

The purpose of the study is to measure markers of inflammatory and oxidative stress known to be associated with cardiovascular morbidity in snoring children.

In addition, to measure markers of local inflammation and to evaluate the response to treatment.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
6 Months to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • children ages 6 months-18 years
  • suspected sleep-disordered breathing or will attend the pre-operative ENT clinic for adenoidectomy or adenotonsillectomy

Exclusion Criteria

  • craniofacial abnormalities
  • neurological disorders
  • genetic disorders
  • infectious disease
  • chronic inflammatory disease
  • any underlying chronic medical condition

Outcomes

Primary Outcomes

Plasma inflammatory-markers

Time Frame: After the blood analyzed

Sleep disordered breathing (SDB) in children is associated with increased markers of inflammation, atherogenesis and oxidative stress.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials